Welcome to our dedicated page for abrdn World Healthcare Fund news (Ticker: THW), a resource for investors and traders seeking the latest updates and insights on abrdn World Healthcare Fund stock.
The abrdn World Healthcare Fund (symbol: THW) is a diversified closed-end management investment company, targeting both current income and long-term capital appreciation through investments in U.S. and non-U.S. companies within the healthcare industry. Managed by Tekla Capital Management LLC, the fund seeks to capitalize on growth opportunities across several healthcare sub-sectors including pharmaceuticals, biotechnology, healthcare services, and medical devices.
THW focuses on investing in public equity markets globally, specifically in the life sciences sector. This encompasses biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare IT & services, and various other related industries like agriculture and environmental management. With a preference for growth stocks of small-cap companies, the fund utilizes fundamental analysis to identify investment opportunities based on factors such as market position, management experience, technological expertise, and financial stability.
The fund's investment approach is structured to benchmark its performance against indices such as the NASDAQ Biotech Index and the S&P 500 Index, ensuring a robust and competitive portfolio. Recently, the fund has been actively involved in several projects aimed at enhancing its investment footprint across emerging markets. These initiatives reflect THW's commitment to seeking innovative healthcare solutions and fostering sustainable growth.
Financially, the abrdn World Healthcare Fund maintains a stable condition, supported by strategic partnerships that provide both funding and market leverage. The fund continues to refine its portfolio, capitalizing on promising ventures within the dynamic healthcare landscape.
For investors seeking exposure to the healthcare sector, THW offers a compelling mix of income generation and capital appreciation potential, backed by a seasoned management team and a diversified portfolio that spans multiple high-growth industries.
Tekla World Healthcare Fund (NYSE: THW) has completed its one-for-three non-transferable rights offering, which expired on April 6, 2021. Shareholders could purchase one newly issued share for every three rights held at a subscription price of $14.262 per share, equating to 95% of the volume weighted average price on the NYSE. The offering attracted total subscriptions of approximately $100.4 million, including oversubscriptions. Shares are expected to be issued around April 9, 2021.
Tekla World Healthcare Fund has renewed its share repurchase program, allowing the purchase of up to 12% of outstanding common shares until July 14, 2022. This initiative aims to enhance shareholder value and reduce the market price discount relative to the net asset value per share. The timing and amount of repurchases will be at the discretion of Tekla Capital Management. However, there is no guarantee that share repurchases will increase market prices or net asset value.
On March 9, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share, with a record date of March 19, 2021. The payment will be made on March 31, 2021, and the fund will trade ex-distribution on March 18, 2021. Only participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested in shares. The fund specializes in investments within the healthcare sector and is advised by Tekla Capital Management.
Tekla World Healthcare Fund announced a non-transferable rights offering that allows shareholders to subscribe for additional shares. Shareholders of record as of March 8, 2021, will receive rights to acquire one share for every three rights held. The rights can be exercised from March 16 to April 6, 2021. The subscription price will be based on a formula related to the volume-weighted average price of shares on the NYSE. This offering aims to increase the Fund's assets, potentially lowering fixed expenses as a percentage of net assets.
On February 9, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is February 19, 2021, with payment scheduled for February 26, 2021. The Fund's shares will trade ex-distribution on February 18, 2021. Only participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have their distributions automatically reinvested in Fund shares. Tekla World Healthcare Fund (NYSE: THW) focuses on healthcare investments and is managed by Tekla Capital Management LLC.
On January 11, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share. The record date is January 21, 2021, with payment scheduled for January 29, 2021. The Fund will trade ex-distribution on January 20, 2021. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan (DRIP) will see automatic reinvestment of distributions. Tekla World Healthcare Fund, listed under the ticker THW, focuses on investments in the healthcare sector and is managed by Tekla Capital Management LLC.
On January 7, 2021, Tekla World Healthcare Fund's Board of Trustees authorized a preliminary registration statement for a proposed rights offering to shareholders. The offering aims to acquire additional shares, with key details yet to be established. Proceeds from the offering would enable the Fund to seize new investment opportunities while maintaining existing holdings. Shareholders will receive non-transferable rights to acquire additional shares, with the subscription price expected below the market price at that time. The offering period and record date will be announced later.
On December 8, 2020, Tekla World Healthcare Fund declared a monthly cash distribution of $0.1167 per share, with a record date of December 18, 2020, and a payable date of December 31, 2020. The Fund will trade ex-distribution on December 17, 2020. Cash distributions will be automatically reinvested in shares for participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan. As a closed-end fund, Tekla World Healthcare Fund, trading under NYSE: THW, focuses on investment in healthcare companies and is advised by Tekla Capital Management LLC.
On November 30, 2020, Tekla World Healthcare Fund (THW) distributed $0.1167 per share. This distribution primarily stems from return of capital rather than net investment income or realized capital gains. The fund reported net unrealized appreciation of portfolio securities at approximately $22 million, despite cumulative total returns at NAV showing a -5.47% decline for the fiscal year. The annualized current distribution rate is 10.57% as of October 31, 2020. Distributions may vary monthly based on realized gains and losses, and actual amounts for tax purposes will be finalized at the fiscal year's end.
On November 9, 2020, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share, with the record date set for November 20, 2020 and a payable date of November 30, 2020. The Fund's shares will trade ex-distribution on November 19, 2020. This closed-end fund focuses on investments within the healthcare sector and is managed by Tekla Capital Management LLC. It is important to note that only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their cash distributions automatically reinvested.
FAQ
What is the current stock price of abrdn World Healthcare Fund (THW)?
What is the market cap of abrdn World Healthcare Fund (THW)?
What is the investment objective of abrdn World Healthcare Fund (THW)?
Which sectors does THW invest in?
Who manages the abrdn World Healthcare Fund?
What types of companies does THW primarily invest in?
What benchmarks does THW use to measure its performance?
What analysis method does THW employ?
What is the financial condition of the abrdn World Healthcare Fund?
Why should investors choose THW?
What recent projects has THW been involved in?
What is the role of partnerships in THW's strategy?
